LRCH1, or leucine-rich repeats and calponin homology (CH) domain containing 1, is a protein encoded by the LRCH1 gene in humans. It belongs to a family of proteins characterized by leucine-rich repeat (LRR) domains, which are typically involved in protein-protein interactions and have a broad range of functions in cellular processes. The calponin homology domain is commonly found in cytoskeletal and signaling proteins and is implicated in linking signal transduction to the cytoskeleton.LRCH1 is thought to participate in the regulation of cytoskeletal dynamics due to its CH domain. This domain's ability to bind actin suggests that LRCH1 may play a role in stabilizing actin filaments or mediating the formation of actin structures within the cell. The LRR domains further imply its potential involvement in cellular signaling pathways and protein complex assembly.
The precise function of LRCH1 remains to be fully elucidated. However, due to its structural domains, LRCH1 is postulated to serve as a scaffold protein that brings together various components of the signaling and cytoskeletal systems, potentially influencing processes such as cell shape, motility, and intracellular signaling cascades. Its expression patterns and involvement in specific cell types or tissues may provide clues to its functions and regulatory mechanisms.Alterations in LRCH1 have been implicated in certain pathologies, including osteoarthritis, suggesting a role in joint health and the maintenance of cartilage. Studies have also associated genetic variations in the LRCH1 gene with susceptibility to this condition, highlighting its potential relevance in both the structural integrity of cartilage and the complex signaling pathways involved in joint biology.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA activates protein kinase C (PKC), which is involved in signal transduction pathways that could intersect with those regulated by LRCH1. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin activates adenylate cyclase, increasing cAMP levels, which may indirectly influence pathways associated with LRCH1. | ||||||
Y-27632, free base | 146986-50-7 | sc-3536 sc-3536A | 5 mg 50 mg | $186.00 $707.00 | 88 | |
A ROCK inhibitor that may indirectly influence LRCH1 activity through cytoskeletal regulation pathways. | ||||||
NSC 23766 | 733767-34-5 | sc-204823 sc-204823A | 10 mg 50 mg | $151.00 $609.00 | 75 | |
Inhibits Rac1, a GTPase involved in actin cytoskeleton organization, potentially affecting LRCH1-associated pathways. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
A PI3K inhibitor, potentially affecting downstream pathways that could intersect with LRCH1 functions. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $64.00 $246.00 | 136 | |
A MEK inhibitor, which could indirectly influence LRCH1 through the MAPK/ERK pathway. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
Inhibits JNK, potentially affecting signaling pathways related to LRCH1. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
A p38 MAPK inhibitor, potentially impacting pathways associated with LRCH1. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
An mTOR inhibitor, which may indirectly affect LRCH1 activity by modulating cellular growth and metabolism pathways. | ||||||